AUG 12, 2026 · PHASE 3 TRIAL
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
ClinicalTrials.gov
This is a Phase 3 registration with no posted results; the trial is actively recruiting and outcomes have not yet been reported.
Reported
Estimated enrollment330
Primary outcome measureMontgomery-Asberg Depression Scale (MADRS)
Planned assessment timepointsScreening Day-45, Baseline, Day -1, Day 21,…